Anesthesia

Your Article Summary

See Latest Articles

PRO: hydroxyethylstarch can be safely used in the intensive care patient--the renal debate
Intensive Care Medicine, 06/19/09

Boldt J - Hyperoncotic HES should not be used in patients who are at risk of developing kidney dysfunction. In patients without preexisting kidney dysfunction there seems to be no negative effects of modern HES preparations. In septic patients with reduced kidney function HES should be used cautiously, because studies of these patients are not available. Dissolving HES in a balanced solution further improves the safety of HES with regard to kidney function. At present, there seems to be no good reason to generally ban use of HES in the patients.

Today in Critical Care...keeping you current

Receive free subspecialty "5-minute updates" via email

Meta-analysis: Ventilation Strategies and Outcomes of the Acute Respiratory Distress Syndrome and Acute Lung Injury
Annals of Internal Medicine, 10/20/09

One year mortality of patients treated with an emergency department based early goal directed therapy protocol for severe sepsis and septic shock: a before and after study
Critical Care, 10/27/09

Significance of arterial hypotension after resuscitation from cardiac arrest
Critical Care Medicine, 10/23/09

See All of Critical Care

Today in Maintenance Solutions...keeping you current

Receive free subspecialty "5-minute updates" via email

Emerging trends in minimally invasive haemodynamic monitoring and optimization of fluid therapy
European Journal of Anaesthesiology, 10/15/09

Magnesium Sulphate as Rescue Haemodynamic Stabilizer During Phaeochromocytoma Excision
Journal of Anaesthesiology Clinical Pharmacology, 10/20/09

Osmolarity and partitioning of fluids
Anaesthesia & intensive care medicine, 11/02/09

See All of Maintenance Solutions